iCAD Inc. (ICAD) Financial Statements (2026 and earlier)

Company Profile

Business Address 98 SPIT BROOK ROAD, SUITE 100
NASHUA, NH 03062
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments17,20618,79320,35320,28421,67019,046
Cash and cash equivalent17,20618,79320,35320,28421,67019,046
Receivables7,2075,4155,3836,5156,3924,865
Inventory, net of allowances, customer advances and progress billings756689702750917992
Inventory756689702750917992
Disposal group, including discontinued operation      5,837
Other undisclosed current assets1,2581,2091,3771,4956991,603
Total current assets:26,42726,10627,81529,04429,67832,343
Noncurrent Assets
Operating lease, right-of-use asset177232286522461514
Property, plant and equipment1,7161,6691,7761,9381,8231,285
Intangible assets, net (including goodwill)8,4638,4738,4838,4988,5108,539
Goodwill8,3628,3628,3628,3628,3628,362
Intangible assets, net (excluding goodwill)101111121136148177
Contract with customer, asset, after allowance for credit loss  48548529015743
Disposal group, including discontinued operation, noncurrent assets      2,996
Deferred income tax assets  78869497104
Other undisclosed noncurrent assets75764896924
Total noncurrent assets:11,11311,00111,12411,35111,74013,485
TOTAL ASSETS:37,54037,10738,93940,39541,41845,828
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2,3582,7973,0222,3902,4483,483
Accounts payable1,1114225016357121,098
Accrued liabilities2,3582,3752,5211,7552,4482,385
Other undisclosed accounts payable and accrued liabilities (1,111)   (712) 
Deferred revenue3,8633,4753,3173,5543,4003,343
Disposal group, including discontinued operation      4,389
Other undisclosed current liabilities1,340224220216900197
Total current liabilities:7,5616,4966,5596,1606,74811,412
Noncurrent Liabilities
Liabilities, other than long-term debt1,2871,2311,4131,7681,2473,381
Deferred revenue1,1371,0231,1641,462974844
Deferred income tax liabilities      6
Disposal group, including discontinued operation, liabilities      2,214
Other liabilities1717    
Operating lease, liability133191249306273317
Other undisclosed noncurrent liabilities87776 
Total noncurrent liabilities:1,2951,2381,4201,7751,2533,381
Total liabilities:8,8567,7347,9797,9358,00114,793
Equity
Equity, attributable to parent28,68429,37330,96032,46033,41731,035
Common stock265265265265265264
Treasury stock, value(1,415)(1,415)(1,415)(1,415)(1,415)(1,415)
Additional paid in capital307,133306,968306,754306,515306,250305,924
Accumulated deficit(277,299)(276,445)(274,644)(272,905)(271,683)(273,738)
Total equity:28,68429,37330,96032,46033,41731,035
TOTAL LIABILITIES AND EQUITY:37,54037,10738,93940,39541,41845,828

Income Statement (P&L) ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
Revenues5,4084,2175,0294,9544,7404,073
Cost of revenue
(Cost of Product and Service Sold)
(738)(583)(812)(841)(418)(552)
Gross profit:4,6703,6344,2174,1134,3223,521
Operating expenses(5,535)(5,649)(6,165)(5,554)(5,039)(4,740)
Operating loss:(865)(2,015)(1,948)(1,441)(717)(1,219)
Nonoperating income90220217223181186
Investment income, nonoperating 210206203201195
Other nonoperating income (expense) 101120(6)(9)
Interest and debt expense     (14) 
Other undisclosed loss from continuing operations before equity method investments, income taxes (12)     
Loss from continuing operations before equity method investments, income taxes:(787)(1,795)(1,731)(1,218)(550)(1,033)
Other undisclosed income from continuing operations before income taxes 12   14 
Loss from continuing operations before income taxes:(775)(1,795)(1,731)(1,218)(536)(1,033)
Income tax expense (79)(6)(8)(4)(7)(4)
Net loss:(854)(1,801)(1,739)(1,222)(543)(1,037)
Other undisclosed net income (loss) attributable to parent     2,598(337)
Net income (loss) available to common stockholders, diluted:(854)(1,801)(1,739)(1,222)2,055(1,374)

Comprehensive Income ($ in thousands)

3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
Net loss:(854)(1,801)(1,739)(1,222)(543)(1,037)
Comprehensive loss, net of tax, attributable to parent:(854)(1,801)(1,739)(1,222)(543)(1,037)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: